ciprofloxacin has been researched along with Alloxan Diabetes in 3 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Excerpt | Relevance | Reference |
---|---|---|
"The therapeutic efficacy of ofloxacin, ciprofloxacin and NY-198 was compared in alloxan-induced diabetic mice with experimental respiratory and urinary tract infections." | 3.67 | Therapeutic efficacy of ofloxacin, ciprofloxacin and NY-198 in experimentally infected normal and alloxan-induced diabetic mice. ( Nishino, T; Obana, Y, 1988) |
"Methylene blue (MB) was incorporated into monolayered random CA/PEO nanofibers." | 1.62 | Photoactive electrospun cellulose acetate/polyethylene oxide/methylene blue and trilayered cellulose acetate/polyethylene oxide/silk fibroin/ciprofloxacin nanofibers for chronic wound healing. ( Abdel Gaber, SA; Abdel Khalek, MA; El-Domany, RA; El-Kemary, MA, 2021) |
"CIP displayed linear PK with dose proportional increase in Cmax and AUCinf in plasma." | 1.56 | Pharmacokinetics/Pharmacodynamics (PK/PD) of Ciprofloxacin in the Complicated Urinary Tract Infection (cUTI) Model in Diabetic Mice. ( Hiremath, S; Jayaraman, R; Nanjundappa, M; Pawar, A; Puttarangappa, P; Puttaswamy, R; Reniguntla, MK; Yedle, R, 2020) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Abdel Khalek, MA | 1 |
Abdel Gaber, SA | 1 |
El-Domany, RA | 1 |
El-Kemary, MA | 1 |
Reniguntla, MK | 1 |
Yedle, R | 1 |
Puttaswamy, R | 1 |
Puttarangappa, P | 1 |
Hiremath, S | 1 |
Pawar, A | 1 |
Nanjundappa, M | 1 |
Jayaraman, R | 1 |
Obana, Y | 1 |
Nishino, T | 1 |
3 other studies available for ciprofloxacin and Alloxan Diabetes
Article | Year |
---|---|
Photoactive electrospun cellulose acetate/polyethylene oxide/methylene blue and trilayered cellulose acetate/polyethylene oxide/silk fibroin/ciprofloxacin nanofibers for chronic wound healing.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Cellulose; Ciprofloxacin; Diabetes Mellitus, Experimental; | 2021 |
Pharmacokinetics/Pharmacodynamics (PK/PD) of Ciprofloxacin in the Complicated Urinary Tract Infection (cUTI) Model in Diabetic Mice.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Ciprofloxacin; Diabetes Mellitus, Experimental; Es | 2020 |
Therapeutic efficacy of ofloxacin, ciprofloxacin and NY-198 in experimentally infected normal and alloxan-induced diabetic mice.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Diabetes Mellitus, Experimental; Female; Fluoroquinol | 1988 |